Collectively, these findings establish NF-κB p65 and PPARγ as experimentally validated hub targets of asiatic acid in osteoporosis, whereas direct modulation of IL-6 and STAT3 has remained insufficiently characterized. The gene discussed is STAT3; the disease is osteoporosis.